Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86462 | Target Info | |||
Target Name | Transthyretin (TTR) | ||||
Synonyms | TBPA; Prealbumin; PALB; ATTR | ||||
Target Type | Successful Target | ||||
Gene Name | TTR | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid | Ligand Info | |||
Canonical SMILES | CC(CON=C1C2=CC=CC=C2C3=CC=CC=C31)C(=O)O | ||||
InChI | 1S/C17H15NO3/c1-11(17(19)20)10-21-18-16-14-8-4-2-6-12(14)13-7-3-5-9-15(13)16/h2-9,11H,10H2,1H3,(H,19,20)/t11-/m0/s1 | ||||
InChIKey | ZHFDVDMCVXUGGF-NSHDSACASA-N | ||||
PubChem Compound ID | 46937059 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4TQI Human transthyretin (TTR) complexed with 3-(9H-fluoren-9-ylideneaminooxy)propanoic acid in a dual binding mode | ||||||
Method | X-ray diffraction | Resolution | 1.25 Å | Mutation | No | [1] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
||||||
PDB ID: 3GS0 Human transthyretin (TTR) complexed with (S)-3-(9H-fluoren-9-ylideneaminooxy)-2-methylpropanoic acid (inhibitor 16) | ||||||
Method | X-ray diffraction | Resolution | 1.85 Å | Mutation | No | [2] |
PDB Sequence |
KCPLMVKVLD
18 AVRGSPAINV28 AVHVFRKAAD38 DTWEPFASGK48 TSESGELHGL58 TTEEEFVEGI 68 YKVEIDTKSY78 WKALGISPFH88 EHAEVVFTAN98 DSGPRRYTIA108 ALLSPYSYST 118 TAVVTN
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | X-ray crystal structure and activity of fluorenyl-based compounds as transthyretin fibrillogenesis inhibitors. J Enzyme Inhib Med Chem. 2016 Oct;31(5):824-33. | ||||
REF 2 | Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis. PLoS One. 2009 Jul 21;4(7):e6290. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.